Gland Pharma IPO Review

IPO Status: Listed [9th Nov 2020 to 11th Nov 2020]

Rated 3.5/5 by Team InvestorGain

Gland Pharma IPO Details

IPO Issue Opening Date:	9th Nov 2020
IPO Issue Closing Date:	11th Nov 2020
IPO Issue Price:	₹1490-1500 Per Share
DRHP:	Download DRHP
RHP:	Download RHP
Anchor List:	Download Anchor List
IPO Listing At:	BSE, NSE
Retail Quota:	50
IPO Issue Type:	Book Build Issue
IPO Issue Size:	Aggregating up to ₹6,479.55 Cr
Offer for Sale:	34,863,635 shares
Fresh Issue:	Aggregating upto ₹1250 Crore
Face Value:	₹1 Per Equity Share
IPO Discount:	NA
Promoter Holding Pre IPO:	74%
Promoter Holding Post IPO:	58.36%
Allotment Status:	Allotment Status

Gland Pharma IPO Important Dates

Get important updates regarding Gland Pharma IPO tentative timeline covering IPO opening, closing, allotment, and listing dates. Dates are updated as they are announced.

Gland Pharma IPO dates
IPO Activity	Date
Basis of Allotment Date*	17th Nov 2020
Refunds Initiation*	18th Nov 2020
Credit of Shares to Demat*	19th Nov 2020
IPO Listing Date*	20th Nov 2020

* - Tentative Dates

Gland Pharma IPO Lots

IPO Activity	Date
Issue Price	₹1490-1500
Market Lot:	10 Shares
1 Lot Amount:	₹15000
Min Small HNI Lots(2-10 Lakh):	140 shares(14 lots)
Min Big HNI Lots(10+ Lakh):

Gland Pharma IPO GMP**

GMP Date	IPO Price	GMP	Sub2 Sauda Rate	Expected Listing Gain	Last Updated
18-11-2020	1500	118	--	₹1618 (7.87%)	18-Nov-2020 14:54

IPO Live GMP

Zerodha Trade@20

The Pioneer Discount Broker
Get 100% Free Delivery Trading
Free Direct Mutual Funds & SIP

Open Demat Account

**The GMP prices shown here are only news related to the grey market. We do not trade/deal in grey market or subject to rates (sub2), nor do we recommend trading in grey market.

About Company - Gland Pharma

What is Gland Pharma IPO?

Gland Pharma IPO is opening for subscription from 9th Nov 2020 to 11th Nov 2020. The IPO (India's largest pharma IPO) issue size is Rs 6,479.55 crore (Fresh issue of Rs 1250 crore and offer for sale of ~Rs 5230 crore). Gland Pharma IPO price band is Rs 1490 - Rs 1500 and IPO lot size is 10 shares and multiple of it. The IPO floor price is 1490 times, and the cap price is 1500 times the face value. Get here the complete Gland Pharma IPO review including all the information regarding the company like business, objective, strength, weakness, financials, IPO Price, IPO dates, GMP, and much more.

Incorporated Year: 1978
Sector: Pharmaceutical
Website: www.glandpharma.com
Issue Size: Rs. 6480 Crore

About Company - Gland Pharma Ltd

Gland Pharma Ltd started its journey as a contract manufacturer of liquid parenteral products, and today, it is the world's fastest-growing injectable company. Currently, its product portfolio includes sterile injectables, oncology & ophthalmic, and complex injectables. It delivers its product via liquid vials, pre-filled syringes, bags and drops, and ampoules.

With the growing product portfolio, the company has established seven manufacturing capabilities in India, including 22 Production Lines and 3 Active Pharmaceutical Ingredient (API) units. It keenly focuses on R&D investment and new technology to synthesize complex molecules to produce complex injectables.

The business has a global footprint in 60+ countries across five continents, including the US, Canada, Australia, India, Europe, etc. Its client base includes Sagent Pharmaceuticals, Apotex Inc, Fresenius Kabi USA, LLC, Athnex Pharmaceutical Division, LLC.

Gland Pharma IPO Strengths

Strong portfolio of diverse complex injectables.
Export products in more than 60 countries.
7 Robust manufacturing facilites.
Strong long-term financial track record, revenue and profitability.

Incorporation	Sector	IPO Issue Size	Website
NULL	NULL	Aggregating up to ₹6,479.55 Cr	Gland Pharma Limiteed

Gland Pharma IPO Objective

Gland Pharma IPO funds will be used for the following key purposes

To meet the business working capital requirements.
To finance the capital expenditures requirements of the company.
To finance general corporate purposes.

Company may allocate up to 60% Shares of the QIB Portion to Anchor Investors.

Gland Pharma IPO Live Subscription (NSE + BSE)

The table below is live update of IPO bidding details from NSE and BSE.

Qualified Institutional Buyers: 8,639,394 Shares
Non-Institutional Investors: 6,479,546 Shares
Retail Individual Investor: 15,118,939 Shares

IPO Bidding Live Updates from BSE + NSE
Day		QIB	NII	RII	Total
	# of Shares Offered	8,639,394 (28.57%)	6,479,546 (21.43%)	15,118,939 (50%)	30,237,879
1	9th Nov 2020 17:02	0.00x	0.01x	0.08x	0.04x
2	10th Nov 2020 17:02	0.48x	0.03x	0.15x	0.22x
3	11th Nov 2020 18:02	6.40x	0.51x	0.24x	2.06x

Gland Pharma financial
Gland Pharma IPO Financials	31-March-2020	31-Mar-2019	31-Mar-2018
Total Assets	₹4,086.04 Cr	₹3,523.55 Cr	₹2,929.47 Cr
Total Income	₹2,772.41 Cr	₹2,129.77 Cr	₹1,671.68 Cr
Net Profit/Loss	₹772.86 Cr	₹451.86 Cr	₹321.05 Cr

Company Address

Gland Pharma Limited
Sy. No. 143 - 148, 150 and 151, Near Gandi Maisamma 'X' Roads,
D.P. Pally,Dundigal Medchal-Malkajgiri District, Hyderabad,Telangana-500043
India
Website: Gland Pharma Limiteed
Phone: +91 40 3051 0999
Email: [email protected]

Gland Pharma IPO Registrar

Link Intime India Private Ltd
Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai - 400083
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
Phone: +91-22-4918 6270
Email: [email protected]

Gland Pharma IPO Lead Manager

Gland Pharma IPO Important dates - Issue Open Date, close Date, IPO Listing Date. IPO Details - Offer Size, Issue Size, Type of IPO, Issue Price, Market Lot, BSE Cd, NSE Cd, IPO Listing date. What is the issue open date and close date for Gland Pharma? Should I apply in Gland Pharma IPO?

Last Updated on 30-Jan-2021 23:21:59

User Reviews

1. Vinay Jain Nov 06 2020 07:54:46 PM Reply

Good IPO, but due to the price band and current GMP trend, we will see another SBI Card.

2.1. Rohit Nov 09 2020 01:04:02 PM

Looks like one more flop IPO for retails investor. TCS, Wipro buyback are looking more attractive.